We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.4M
AUM Growth
+$421K
Cap. Flow
+$908K
Cap. Flow %
1.48%
Top 10 Hldgs %
36.09%
Holding
98
New
30
Increased
15
Reduced
28
Closed
20

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.57M
2
HCA icon
HCA Healthcare
HCA
+$2.24M
3
AAPL icon
Apple
AAPL
+$1.87M
4
ELV icon
Elevance Health
ELV
+$1.51M
5
GILD icon
Gilead Sciences
GILD
+$1.48M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.49M
2
AER icon
AerCap
AER
+$2.11M
3
WBA
Walgreens Boots Alliance
WBA
+$1.64M
4
SCHW
Charles Schwab
SCHW
+$1.53M
5
TXT icon
Textron
TXT
+$1.1M

Sector Composition

Rank Sector Weight
1 Healthcare 47.78%
2 Technology 12.67%
3 Financials 6.92%
4 Communication Services 6.07%
5 Consumer Discretionary 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYF icon
26
Synchrony
SYF
$25.6B
$875K 1.43%
30,545
-2,365
-7% -$65.7K
BKD icon
27
Brookdale Senior Living
BKD
$3.4B
$712K 1.16%
+44,831
New +$684K
HAPN
28
Happen Inc
HAPN
$2.24B
$706K 1.15%
+17,008
New +$714K
META icon
29
Meta Platforms (Facebook)
META
$1.51T
$676K 1.1%
5,927
-2,845
-32% -$300K
NFLX icon
30
Netflix
NFLX
$309B
$654K 1.07%
63,990
-7,470
-10% -$73.3K
CLVS
31
DELISTED
Clovis Oncology, Inc.
CLVS
$613K 1%
31,945
-3,355
-10% -$71K
AMAT icon
32
Applied Materials
AMAT
$428B
$577K 0.94%
+27,236
New +$497K
AERI
33
DELISTED
Aerie Pharmaceuticals
AERI
$572K 0.93%
47,065
-2,491
-5% -$39.4K
JAZZ icon
34
CALL
Jazz Pharmaceuticals
JAZZ
$16.7B
$561K 0.91%
+4,300
New +$535K
TFCFA
35
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$546K 0.89%
+19,595
New +$524K
ZLTQ
36
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$542K 0.88%
19,974
+8,302
+71% +$196K
HLF icon
37
Herbalife
HLF
$1.29B
$520K 0.85%
+16,906
New +$436K
CHTR icon
38
Charter Communications
CHTR
$18.2B
$501K 0.82%
2,473
+39
+2% +$7K
HYG icon
39
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$490K 0.8%
+6,000
New +$476K
XBI icon
40
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$480K 0.78%
+9,300
New +$483K
BDX icon
41
Becton Dickinson
BDX
$48.7B
$468K 0.76%
+3,159
New +$448K
ARAY icon
42
Accuray
ARAY
$34M
$456K 0.74%
78,883
-504
-0.6% -$2.79K
CRM icon
43
Salesforce
CRM
$158B
$449K 0.73%
+6,080
New +$419K
INVA icon
44
Innoviva
INVA
$1.48B
$428K 0.7%
33,973
-17,414
-34% -$191K
EEM icon
45
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$421K 0.69%
+12,300
New +$381K
RAD
46
DELISTED
Rite Aid Corporation
RAD
$403K 0.66%
2,471
-16
-0.6% -$2.52K
TCOM icon
47
Trip.com Group
TCOM
$29.1B
$373K 0.61%
+8,431
New +$353K
BPMC
48
DELISTED
Blueprint Medicines
BPMC
$339K 0.55%
18,788
+736
+4% +$12.8K
AET
49
DELISTED
Aetna Inc
AET
$336K 0.55%
2,991
-8,084
-73% -$865K
DVA icon
50
DaVita
DVA
$11.7B
$333K 0.54%
+4,544
New +$307K
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2016 Portfolio in Review

As of Q1 2016, Partner Investment Management held 98 positions worth $61.4M, up 0.69% from $61M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Partner Investment Management's Q1 2016 filing shows 30 new, 15 increased, 28 reduced and 20 closed positions. Its largest new stake was AbbVie: 46,029 shares worth $2.63M. The largest sale was Teva Pharmaceuticals, an estimated $2.49M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

  • Partner Investment Management's largest Q1 2016 buy was AbbVie: 46,029 shares worth $2.63M.
  • Partner Investment Management added most to HCA Healthcare in Q1 2016, an estimated $2.24M increase.
  • Partner Investment Management's biggest Q1 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.64M.
  • Partner Investment Management fully exited Teva Pharmaceuticals in Q1 2016, selling an estimated $2.49M.
  • Partner Investment Management's ten largest holdings make up 36% of its $61.4M portfolio in Q1 2016.
  • Partner Investment Management opened 30 new positions and closed 20 in Q1 2016.
  • Partner Investment Management's portfolio value rose 0.69% quarter-over-quarter to $61.4M.

Based on Partner Investment Management's 13F filing for Q1 2016, filed 16 May 2016.